Sorrento SRNE has 33.2% of float short. It ran from 2 to 20 last year and from 7 to 17 this month, now under 13. Hindenburg got involved in shorting after CEO was on Mad Money. They have a large Covid portfolio. Waiting for EUA For rapid test. They also have antibody nose drops for right after exposure and stem cells for ICU patients on oxygen. 1st 3 treated with stem cells were discharged within a week. Analyst Riley gave 26 price target today. Sorrento owns 25% of Cellularity which is doing a SPAC soon with GXGX Also they are suing the richest MD in the world who owns LA Times - he bought rights to a cancer drug and then killed it so his other drug would sell more. SRNE will settle soon for $1 billion.
Anyway, check it out. Active board on iHub Thanks Steve for the invitation. I love your casinos
News 
Market Data 
Discover 
